OZYMF Intrinsic Valuation and Fundamental Analysis - Strategic Partners A/S

Watchlist Manager

Watchlist

Price: 90 USD Market Closed

Market Cap: $6.4m

S	Strategic Partners A/S OTC:OZYMF	DK
C	Cupani Metals Corp CNSX:CUPA	CA
	Kelso Technologies Inc F:LB4A	CA
F	Food and Drinks PCL SET:F&D	TH
A	Asia Metal PCL SET:AMC	TH
T	Thai Optical Group PCL SET:TOG	TH
	Saratoga Investama Sedaya Tbk PT F:ZY8	ID

Intrinsic Value

Is OZYMF undervalued or overvalued?

See the intrinsic value estimate for Strategic Partners A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

OZYMF Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with OZYMF’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price $90

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Strategic Partners A/S Does

Biotechnology Health Care

Strategic Partners A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. The company develops new therapies for the treatment of a family of genetic disorders. The firm's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases.

Headquarters: Denmark DK
Employees: 1
IPO date: Nov 17, 2017